Prognosis
EU Seeks Up to 300 Million More Pfizer-BioNTech Doses
- Bloc said to pursue deal that could double Pfizer shot supply
- Purchase would include 100 million orders, 200 million options
This article is for subscribers only.
The European Union is negotiating with Pfizer Inc. and BioNTech SE on a deal that could double their supply of Covid-19 vaccine to the region as countries race to immunize enough people to tame a fresh virus resurgence.
The new contract would include 100 million doses, as well as an option for as many as 200 million more, according to people familiar with the talks who asked not to be identified because the negotiations are private.